-
Dec 24, 2024Parkin Gene Deficiency Monkey Model Reveals New Mechanisms And Therapeutic Ta...New Breakthrough in Parkinson's Disease Research: Parkin Gene Deficiency Monkey Model Reveals New Mechanisms and Therapeutic Targets for Parkinson's Disease -
Dec 20, 2024Nonclinical Drug Development Guide: Acute, Subacute, Subchronic, And Chronic ...Prisys Biotech specializing in nonhuman primate pharmacology and disease models. Our innovative approaches bridge the gap between preclinical research and clinical trials, provi... -
Dec 16, 2024Innovative Nasal-to-Brain (N2B) Drug Delivery: Bypassing The Blood-Brain BarrierDiscover the cutting-edge nasal-to-brain (N2B) drug delivery method. Learn how this non-invasive approach bypasses the blood-brain barrier to deliver therapeutics directly to th... -
Dec 09, 2024Opportunities And Challenges Of Mini Pigs As A Nonclinical Large Animal SpeciesExplore the growing role of miniature pigs in nonclinical research, their physiological similarities to humans, and the challenges and opportunities they present as an alternati...
-
Dec 03, 2024Drug Delivery Strategies For Brain DiseasesExplore the latest advancements in drug delivery strategies for brain diseases, including non-invasive, invasive, and emerging techniques, and their potential to overcome the bl...
-
Nov 28, 2024Real-time Intraoperative MRI Navigation: Supporting FDA Approval Of The First...Explore Prisys Biotech's pioneering use of real-time intraoperative MRI (RT-iMRI) technology for precision brain delivery. Learn how this breakthrough supported FDA approval of ...
-
Nov 26, 2024Ocular Toxicity Studies Of Eye Drops: Drug Exposure And Safety EvaluationExplore ocular toxicity studies for eye drops, focusing on drug exposure, transport mechanisms, and safety evaluations. Learn about the implications for anterior and posterior s...
-
Nov 19, 2024Prisys Biotech Establishes Cynomolgus Monkey Psoriasis Model To Accelerate Dr...Discover Prisys Biotech's innovative cynomolgus monkey psoriasis model, a breakthrough in preclinical drug research that simulates human pathophysiology for effective psoriasis ...
-
Nov 15, 2024Comprehensive Non-Human Primate Models For Renal Disease Research By Prisys B...Explore Prisys Biotech's comprehensive non-human primate (NHP) renal disease models designed for acute kidney injury (AKI) and chronic kidney disease (CKD) research. Our models ...
-
Nov 11, 2024Comprehensive Preclinical Safety Evaluation Of Antibody-Drug Conjugates (ADCs...Prisys Biotech excels in preclinical ADC safety evaluations using non-human primate models, offering insights into ADC toxicokinetics, immunogenicity, tissue cross-reactivity, a...
-
Nov 08, 2024Pharmacokinetics Evaluation Of Antibody-Drug Conjugates (ADCs) in Non-Human P...Explore Prisys Biotech's advanced expertise in ADC pharmacokinetics evaluation using non-human primate models. Our CRO specializes in comprehensive PK analysis, stability studie...
-
Nov 06, 2024Pharmacodynamics Evaluation Of ADCsPrisys Biotech leads in ADC pharmacodynamics evaluation using advanced disease modeling in non-human primates. Our comprehensive assessment solutions span target affinity testin...
